Bayer
Bayer is a global enterprise with core competencies in the fields of health care, agriculture and high-tech polymer materials. As an innovation company, it sets trends in research-intensive areas. Bayer's products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen. In fiscal 2014, the Group employed 118,900 people and had sales of EUR 42.2 billion. Capital expenditures amounted to EUR 2.5 billion, R&D expenses to EUR 3.6 billion.
Business & Industry
- Consignment of 30 million hydroxychloroquine tablets ships to US Department of Health and Human Services
- Novartis and life sciences companies commit expertise and assets to the fight against COVID-19 pandemic alongside Bill & Melinda Gates Foundation
- Amgen and the Amgen Foundation commit up to $12.5 million to support COVID-19 relief efforts
- Roche response to COVID-19 pandemic
- AstraZeneca to donate 9 million face masks to support healthcare workers around the world in the fight against COVID-19
Research & Development
- FDA approves first plasma therapy for Houston Methodist COVID-19 patient
- Experimental AI tool predicts which COVID-19 patients develop respiratory disease
- Nafamostat is expected to prevent the transmission of new coronavirus infection (COVID-19)
- Singapore modelling study estimates impact of physical distancing on reducing spread of COVID-19
- CAR macrophages go beyond T cells to fight solid tumors
- Vivli to launch a portal for sharing data from COVID-19 trials
- Understanding how COVID-19 affects children vital to slowing pandemic
Conferences & Events
- Pre-Filled Syringes West Coast 2021
- Pre-Filled Syringes East Coast Conference 2020
- SMi's 4th Annual Pharmaceutical Microbiology West Coast
- SMi's 20th Annual Pain Therapeutics Conference 2020
- SMi's 3rd Annual Pharmaceutical Microbiology East Coast
- SMi's 22nd Annual Superbugs & Superdrugs Conference 2020
- SMi Presents the 3rd Annual Conference: Injectable Drug Delivery 2020
Regulatory Affairs
- The FDA is facilitating access to convalescent plasma collected from recovered COVID-19 patients
- FDA continues to facilitate development of COVID-19 treatments
- FDA and FTC warn seven companies selling fraudulent products that claim to treat or prevent COVID-19
- FDA approves new treatment for adults with Cushing's disease
- FDA approves first generic of Daraprim